Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN54551960
ISRCTN54551960
Completed
Not Applicable

Markers for Acute Chemotherapy-Induced Cardiovascular Changes

niversity Medical Center Groningen (UMCG), Department of Internal Medicine: Division of Medical Oncology (The Netherlands)0 sites50 target enrollmentJuly 19, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTesticular cancerCancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Testicular cancer
Sponsor
niversity Medical Center Groningen (UMCG), Department of Internal Medicine: Division of Medical Oncology (The Netherlands)
Enrollment
50
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
niversity Medical Center Groningen (UMCG), Department of Internal Medicine: Division of Medical Oncology (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with disseminated testicular cancer who will be treated with cisplatin based chemotherapy
  • •2\. Age 18\-50 years at start of treatment
  • •3\. Written informed consent

Exclusion Criteria

  • •1\. Medical history of cardiovascular disease
  • •2\. Known renal disease or estimated glomerular filtration rate (GFR) \<60 ml/min (using Cockcroft\-Gault formula)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.CardiotoxicityChemotherapy EffectChemotherapy Induced Systolic Dysfunction
NCT05992337Cardiology Prague200
Completed
Not Applicable
Detection of chemotherapy induced cardiac TOXicity in breast cancer studyPatients with breast cancer undergoing anthracycline chemotherapy
JPRN-UMIN000014741Department of Cardiovascular Medicine, Kyoto University Hospital100
Completed
Not Applicable
Detection of Chemotherapy Induced CardiotoxicityCancer
NCT00636844George Washington University36
Terminated
Not Applicable
Cardiotoxic Effects of Chemotherapy in Patients With Sarcomas: A Two and Three-dimensional Echocardiographic Speckle Tracking Imaging StudySarcoma
NCT06511388Mayo Clinic400
Active, not recruiting
Phase 1
A new magnetic resonance scanning technology for monitoring therapy effects in patients with Pancreatic cancer.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]MedDRA version: 20.0Level: LLTClassification code 10033575Term: Pancreas cancerSystem Organ Class: 100000004864
EUCTR2016-004491-22-DKDept. Clinical Medicine, Aarhus Universit15